New Key Statistics Module, Z-Score and F-Score
NAS:SCPH Key Ratios
| Market Cap $ M | 171.14 |
| Enterprise Value $ M | 132.15 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.57 |
| Price/Sales | 4.65 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 30.00 |
| EPS (TTM) $ | -1.90 |
| Beneish M-Score | 0.14 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 6.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.84 |
| EV-to-EBITDA | -1.86 |
| PEG | -- |
| Shares Outstanding M | 50.04 |
| Net Margin (%) | -264.60 |
| Operating Margin % | -210.35 |
| Pre-tax Margin (%) | -264.60 |
| Quick Ratio | 6.89 |
| Current Ratio | 8.08 |
| ROA % (ttm) | -85.31 |
| ROE % (ttm) | -265.48 |
| ROIC % (ttm) | -459.80 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.42 |
SCPH Number of Guru Trades
SCPH Volume of Guru Trades
Gurus Latest Trades with NAS:SCPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SCPH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
scPharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SCPH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers